These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17686286)

  • 21. Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.
    Kim HR; Christensen R; Park NH; Sapp P; Kang MK; Park NH
    Clin Cancer Res; 2001 Oct; 7(10):3079-86. PubMed ID: 11595698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
    Li F; Tan XH; Peng XJ; Cai HB; Hu DR
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis.
    Wang Z; Xu J; Geng X; Zhang W
    Arch Med Res; 2010 Jan; 41(1):1-6. PubMed ID: 20430247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
    Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
    Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids.
    Bougel S; Lhermitte B; Gallagher G; de Flaugergues JC; Janzer RC; Benhattar J
    Clin Cancer Res; 2013 Apr; 19(8):2216-23. PubMed ID: 23444211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
    Horikawa I; Cable PL; Afshari C; Barrett JC
    Cancer Res; 1999 Feb; 59(4):826-30. PubMed ID: 10029071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
    Kim SJ; Lee HS; Shin JH; Kim CG; Jeong S; Park K; Choe H; Lee H
    Oncol Rep; 2006 Nov; 16(5):975-9. PubMed ID: 17016580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of HOXC13 in ameloblastoma].
    Zhong M; Wang J; Gong YB; Li JC; Zhang B; Hou L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):43-6. PubMed ID: 17331444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
    Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
    Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.